{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:58:46Z","timestamp":1790283526125,"version":"4.1.0"},"reference-count":42,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"9","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>In many low- and middle-income countries, access to molecularly targeted therapies for lung cancer remains limited. This study assessed the gap between estimated epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment need and observed uptake in Indonesia and evaluated the gap before and after implementation of the National Reimbursement System (NRS). We hypothesized that many potentially eligible patients in Indonesia would not receive EGFR-TKI therapy, as they ideally should.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed all patient cases of lung cancer registered between 2008 and 2020 at Indonesia's national referral hospital. Patients with a registered diagnosis verified by histopathology or supporting clinical evidence were included. Because patient-level molecular and clinical eligibility data were incomplete, EGFR-TKI eligibility was estimated using a stepwise epidemiologic model. A model-based sensitivity analysis was performed to assess robustness. Observed uptake was compared before and after NRS implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1,426 patients with lung cancer were included; 67.8% were male; the median age was 55 years for men and 53 years for women. Of those with known stage and histology, 93.6% were stage IV; adenocarcinoma accounted for 57.2% of patients with non\u2013small cell lung cancer. Under lower-bound, primary, and upper-bound models, estimated eligible populations were 128 (9.0%), 226 (15.8%), and 378 (26.5%) patients, respectively. Only 41 patients received EGFR-TKIs, corresponding to 32.0%, 18.1%, and 10.8% of the estimated eligible population, respectively. After NRS implementation, uptake increased from 0% to 25.0% of the primary estimate; however, a substantial gap persisted throughout the study period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite national reimbursement, EGFR-TKI uptake remained substantially below the estimated need even under the most conservative model. Persistent barriers that span diagnostics, infrastructure, and financing are likely to contribute. Coordinated strategies beyond formulary listings are required to improve access to EGFR-TKI therapy in middle-income settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/go-26-00210","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:59:21Z","timestamp":1790279961000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Gap Between Estimated Need and Observed Uptake of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Among Patients With Lung Cancer in Indonesia"],"prefix":"10.1200","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9859-2267","authenticated-orcid":true,"given":"Oke Dimas","family":"Asmara","sequence":"first","affiliation":[{"name":"Division of Respirology and Critical Illness, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Dr Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia"},{"name":"Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, the Netherlands"},{"name":"Faculty Campus Frysl\u00e1n, University of Groningen, Leeuwarden, the Netherlands"},{"name":"Department of Pulmonary Medicine, Frisius Medical Center, Leeuwarden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3489-2364","authenticated-orcid":true,"given":"Eric Daniel","family":"Tenda","sequence":"additional","affiliation":[{"name":"Division of Respirology and Critical Illness, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Dr Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1816-0112","authenticated-orcid":true,"given":"Fahmi","family":"Radityamurti","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Faculty of Medicine Universitas Indonesia, Dr Cipto Mangunkusumo General Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni Nyoman","family":"Indirawati","sequence":"additional","affiliation":[{"name":"Division of Respirology and Critical Illness, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Dr Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I Putu Eka Krisnha","family":"Wijaya","sequence":"additional","affiliation":[{"name":"Division of Respirology and Critical Illness, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Dr Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia"},{"name":"Department of Pulmonology and Respiratory Medicine, Persahabatan Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadiki","family":"Habib","sequence":"additional","affiliation":[{"name":"Division of Respirology and Critical Illness, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Dr Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herikurniawan","family":"Herikurniawan","sequence":"additional","affiliation":[{"name":"Division of Respirology and Critical Illness, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Dr Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Yulianti","sequence":"additional","affiliation":[{"name":"Division of Respirology and Critical Illness, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Dr Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0734-0660","authenticated-orcid":true,"given":"Gurmeet","family":"Singh","sequence":"additional","affiliation":[{"name":"Division of Respirology and Critical Illness, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Dr Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Telly","family":"Kamelia","sequence":"additional","affiliation":[{"name":"Division of Respirology and Critical Illness, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Dr Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceva Wicaksono","family":"Pitoyo","sequence":"additional","affiliation":[{"name":"Division of Respirology and Critical Illness, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Dr Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Martin","family":"Rumende","sequence":"additional","affiliation":[{"name":"Division of Respirology and Critical Illness, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Dr Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulkifli","family":"Amin","sequence":"additional","affiliation":[{"name":"Division of Respirology and Critical Illness, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Dr Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3584-5778","authenticated-orcid":true,"given":"Anggriyani Wahyu","family":"Pinandari","sequence":"additional","affiliation":[{"name":"Faculty Campus Frysl\u00e1n, University of Groningen, Leeuwarden, the Netherlands"},{"name":"Department of Biostatistics, Epidemiology, and Population Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3927-0599","authenticated-orcid":true,"given":"Yayi Dwina Billianti","family":"Susanto","sequence":"additional","affiliation":[{"name":"Department of Pathology Anatomy, Faculty of Medicine Universitas Indonesia, Dr Cipto Mangunkusumo General Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5307-3671","authenticated-orcid":true,"given":"Lisnawati","family":"Rachmadi","sequence":"additional","affiliation":[{"name":"Department of Pathology Anatomy, Faculty of Medicine Universitas Indonesia, Dr Cipto Mangunkusumo General Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wulyo","family":"Rajabto","sequence":"additional","affiliation":[{"name":"Division of Hematology-Medical Oncology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr Cipto Mangunkusumo General Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3246-3352","authenticated-orcid":true,"given":"Andhika","family":"Rachman","sequence":"additional","affiliation":[{"name":"Division of Hematology-Medical Oncology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr Cipto Mangunkusumo General Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4827-9392","authenticated-orcid":false,"given":"Aru W.","family":"Sudoyo","sequence":"additional","affiliation":[{"name":"Division of Hematology-Medical Oncology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr Cipto Mangunkusumo General Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7928-5309","authenticated-orcid":true,"given":"E. Christiaan","family":"Boerma","sequence":"additional","affiliation":[{"name":"Faculty Campus Frysl\u00e1n, University of Groningen, Leeuwarden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9446-4361","authenticated-orcid":true,"given":"Soehartati A.","family":"Gondhowiardjo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Faculty of Medicine Universitas Indonesia, Dr Cipto Mangunkusumo General Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5976-0974","authenticated-orcid":true,"given":"Wouter H.","family":"van Geffen","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00444-8"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2020.07.009"},{"key":"e_1_3_7_5_2","first-page":"6232","article-title":"Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: Systematic review and meta-analysis","volume":"25","author":"Lee HJ","year":"2021","unstructured":"Lee HJ, Jeong GH, Li H, et al: Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: Systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 25:6232-6244, 2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2306434"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713137"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.08.61"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-021-00563-1"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000033"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2023.06.010"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-024-02851-y"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.52225\/narra.v5i2.1721"},{"key":"e_1_3_7_14_2","first-page":"25","article-title":"Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients","volume":"9","author":"Syahruddin E","year":"2018","unstructured":"Syahruddin E, Wulandari L Sri Muktiati N, et al: Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients. Lung Cancer (Auckl) 9:25-34, 2018","journal-title":"Lung Cancer (Auckl)"},{"key":"e_1_3_7_15_2","first-page":"e29386","article-title":"Clinical laboratory results as prognosis marker in advanced stage non-small cell lung cancer (NSCLC) in Indonesia","volume":"14","author":"Hanafi AR","year":"2022","unstructured":"Hanafi AR, Jayusman AM, Sutandyo N, et al: Clinical laboratory results as prognosis marker in advanced stage non-small cell lung cancer (NSCLC) in Indonesia. Cureus 14:e29386, 2022","journal-title":"Cureus"},{"key":"e_1_3_7_16_2","first-page":"291","article-title":"Non-small cell lung carcinoma in women: A retrospective cohort study in Indonesia","volume":"50","author":"Sutandyo N","year":"2018","unstructured":"Sutandyo N, Suratman E: Non-small cell lung carcinoma in women: A retrospective cohort study in Indonesia. Acta Med Indones 50:291-298, 2018","journal-title":"Acta Med Indones"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1177\/11795549231178172"},{"key":"e_1_3_7_18_2","first-page":"173","article-title":"Efficacy of gefitinib and radiotherapy combination in Indonesian patients with lung adenocarcinoma","volume":"56","author":"Syahruddin E","year":"2018","unstructured":"Syahruddin E, Huswatun AL, Prabowo A, et al: Efficacy of gefitinib and radiotherapy combination in Indonesian patients with lung adenocarcinoma. Rom J Intern Med 56:173-181, 2018","journal-title":"Rom J Intern Med"},{"key":"e_1_3_7_19_2","first-page":"22","article-title":"The time to progression in lung adenocarcinoma patients receiving first- and second-generation EGFR-TKI in Indonesia","volume":"11","author":"Syahruddin ES","year":"2025","unstructured":"Syahruddin ES, Ananda FR, Wulandari L, et al: The time to progression in lung adenocarcinoma patients receiving first- and second-generation EGFR-TKI in Indonesia. J Respi 11:22-30, 2025","journal-title":"J Respi"},{"key":"e_1_3_7_20_2","volume-title":"Pedoman strategi & langkah aksi pengembangan registrasi kanker berbasis populasi","author":"Gondhowiardjo SA","year":"2019","unstructured":"Gondhowiardjo SA, Arianie CP, Taher A (eds): Pedoman strategi & langkah aksi pengembangan registrasi kanker berbasis populasi, Jakarta, Komite Penanggulangan Kanker Nasional, 2019"},{"key":"e_1_3_7_21_2","volume-title":"CanReg5","author":"International Association of Cancer Registries","unstructured":"International Association of Cancer Registries: CanReg5. https:\/\/www.iacr.com.fr\/CanReg5\/"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.13181\/mji.bc.203785"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103996"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.2174\/0118743064318977240531100045"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100560"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.47102\/annals-acadmedsg.V46N9p333"},{"key":"e_1_3_7_27_2","first-page":"70","article-title":"A review of lung cancer research in Malaysia","volume":"71","author":"Kan CS","year":"2016","unstructured":"Kan CS, Chan KMJ: A review of lung cancer research in Malaysia. Med J Malaysia 71:70-78, 2016 (Suppl 1)","journal-title":"Med J Malaysia"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1047644"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-20-22"},{"key":"e_1_3_7_30_2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.35755\/jmedassocthai.2021.S02.12559","article-title":"The prevalence of adenocarcinoma in non-small cell lung cancer patients at chulabhorn Hospital","volume":"104","author":"Supapavej A","year":"2021","unstructured":"Supapavej A, Sungkasubun P, Siripaibun J, et al: The prevalence of adenocarcinoma in non-small cell lung cancer patients at chulabhorn Hospital. J Med Assoc Thai 104:S1-S4, 2021 (suppl 2)","journal-title":"J Med Assoc Thai"},{"key":"e_1_3_7_31_2","first-page":"2892","article-title":"EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: A systematic review and global map by ethnicity (mutMapII)","volume":"5","author":"Midha A","year":"2015","unstructured":"Midha A, Dearden S, McCormack R: EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: A systematic review and global map by ethnicity (mutMapII). Am J Cancer Res 5:2892-2911, 2015","journal-title":"Am J Cancer Res"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S364713"},{"key":"e_1_3_7_33_2","first-page":"1967","article-title":"EGFR mutations in patients with non-small cell lung cancer from mainland China and their relationships with clinicopathological features: A meta-analysis","volume":"7","author":"Wang S","year":"2014","unstructured":"Wang S, Wang Z: EGFR mutations in patients with non-small cell lung cancer from mainland China and their relationships with clinicopathological features: A meta-analysis. Int J Clin Exp Med 7:1967-1978, 2014","journal-title":"Int J Clin Exp Med"},{"key":"e_1_3_7_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181d2dcd9"},{"key":"e_1_3_7_35_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01157-2015"},{"key":"e_1_3_7_36_2","first-page":"491","article-title":"Utilisation patterns and treatment outcomes of EGFR-tyrosine kinase inhibitors in EGFR-mutant advanced lung carcinoma in the Pakistani-Asian population: A real-world data study","volume":"9","author":"Munawar K","year":"2023","unstructured":"Munawar K, Qazi R, Sheikh HS: Utilisation patterns and treatment outcomes of EGFR-tyrosine kinase inhibitors in EGFR-mutant advanced lung carcinoma in the Pakistani-Asian population: A real-world data study. J Cancer Allied Spec 9:491, 2023","journal-title":"J Cancer Allied Spec"},{"key":"e_1_3_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188967"},{"key":"e_1_3_7_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-07868-9"},{"key":"e_1_3_7_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2024.100430"},{"key":"e_1_3_7_40_2","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-23-727"},{"key":"e_1_3_7_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-024-01795-w"},{"key":"e_1_3_7_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30458-6"},{"key":"e_1_3_7_43_2","doi-asserted-by":"publisher","unstructured":"Bamodu OA Chung CC: Cancer care disparities: Overcoming barriers to cancer control in low- and middle-income countries. JCO Glob Oncol 10.1200\/GO.23.00439","DOI":"10.1200\/GO.23.00439"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-26-00210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:59:33Z","timestamp":1790279973000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-26-00210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1200\/GO-26-00210"],"URL":"https:\/\/doi.org\/10.1200\/go-26-00210","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2026-03-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2600210"}}